Brian E. Scully
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 20
- Pneumonia and Respiratory Infections 7
- Mycobacterium research and diagnosis 5
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 15
- Co-authors
- Harold C. Neu (17 shared papers)H. C. Neu (6 shared papers)David R. Spriggs (1 shared paper)Carlton C. McGregor (2 shared papers)Larry L. Schulman (3 shared papers)Toshiharu Hirose (1 shared paper)Edward A. Swabb (1 shared paper)Phyllis Della‐Latta (3 shared papers)
- Journals
- Clinical Infectious Diseases (5 papers)The American Journal of Medicine (4 papers)Diagnostic Microbiology and Infectious Disease (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Circulation (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Brian E. Scully
51 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Molecular Medicine 300
- Applied Microbiology and Biotechnology 78
- Microbiology 26
- Pharmacology 396
- Endocrinology 111
Countries citing papers authored by Brian E. Scully
This map shows the geographic impact of Brian E. Scully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Scully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Scully more than expected).
Fields of papers citing papers by Brian E. Scully
This network shows the impact of papers produced by Brian E. Scully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Scully. The network helps show where Brian E. Scully may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian E. Scully, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 147 | |
| 2 | 2000 | 78 | |
| 3 | 2000 | 70 | |
| 4 | Ciprofloxacin therapy in cystic fibrosis. | 1987 | 69 |
| 5 | 1987 | 68 | |
| 6 | 1985 | 66 | |
| 7 | 2007 | 65 | |
| 8 | 1992 | 52 | |
| 9 | 1983 | 48 | |
| 10 | 1997 | 44 | |
| 11 | 1985 | 44 | |
| 12 | Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection. | 1984 | 44 |
| 13 | 2003 | 43 | |
| 14 | 1984 | 41 | |
| 15 | 1983 | 37 | |
| 16 | 1985 | 36 | |
| 17 | 2010 | 35 | |
| 18 | 2009 | 30 | |
| 19 | 1985 | 26 | |
| 20 | 1985 | 26 |
About Brian E. Scully
Brian E. Scully is a scholar working on Epidemiology, Pharmacology, Molecular Medicine, Infectious Diseases and Surgery, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), Pneumonia and Respiratory Infections (7 papers), Mycobacterium research and diagnosis (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Antibiotic Use and Resistance (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). The work is most often cited by research in Molecular Medicine (300 citations), Applied Microbiology and Biotechnology (78 citations), Microbiology (26 citations), Pharmacology (396 citations) and Endocrinology (111 citations). Brian E. Scully has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Harold C. Neu, H. C. Neu, David R. Spriggs, Carlton C. McGregor, Larry L. Schulman, Toshiharu Hirose, Edward A. Swabb, Phyllis Della‐Latta, Prashant Sinha and Mehmet C. Öz. Their work appears in journals such as Clinical Infectious Diseases, The American Journal of Medicine, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.